Desq Long
Sign in
SEC FORM 4
—

Iambic Therapeutics, Inc. (IAM)

Acquisition (code C) of 742,546 shares; price not stated (see filing).

Reporting Persons Catalio Capital Management, LP · Catalio Nexus Fund III, LP · Catalio Access Fund VIII, LLC · Catalio BH SPV, LLC · Petrocheilos George C · Transaction Code C

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001958125-26-000011 · filed 2026-10-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Iambic Therapeutics, Inc. (IAM)." Disclosed 2026-10-19. https://desqlong.com/cards/0001958125-26-000011-3 (retrieved 2026-10-20).